Abstract P234 – Table 1. Characteristics of HIV population with IBD diagnosis, at the time of the study
| Characteristics of population | N 17 |
|---|---|
| Male sex, n (%) | 17 (100%) |
| Age, years (median IQR) | 44 (37 to 49.5) |
| MSM, n (%) | 13 (77%) |
| CDC class C (%) | 4 (24%) |
| CD4‐T cells nadir (/mm3) | 396 (209 to 586) |
| Years since HIV diagnosis, median (IQR) | 8 (5.5 to 18) |
| CD4‐T cells (/mm3) | 826 (589 to 973) |
| HIV <50 copies/mL, n (%) | 17 (100%) |
| PI‐containing ART regimen, n (%) | 7 (41.2%) |
| HCV Ab positive, n (%) | 8 (47%) |
| Years since IBD diagnosis, median (IQR) | 7.5 (2.25 to 10.5) |
| Ulcerative colitis, n (%) | 17 (100%) |
| UC extent | |
| Proctitis, n (%) | 8 (47%) |
| Distal colitis, n (%) | 1 (6%) |
| Pancolitis, n (%) | 7 (41%) |
| N/A | 1 (6%) |
| Pharmacological treatment for IBD | |
| No treatment, n (%) | 6 (35%) |
| Steroids, n (%) | 1 (6%) |
| Mesalazine, n (%) | 8 (47%) |
| Mesalazine plus steroids, n (%) | 2 (12%) |
| Immunosuppressive drugs, n (%) | 0 |